BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 12080348)

  • 1. Nucleophosmin regulates the stability and transcriptional activity of p53.
    Colombo E; Marine JC; Danovi D; Falini B; Pelicci PG
    Nat Cell Biol; 2002 Jul; 4(7):529-33. PubMed ID: 12080348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MNDA binds NPM/B23 and the NPM-MLF1 chimera generated by the t(3;5) associated with myelodysplastic syndrome and acute myeloid leukemia.
    Xie J; Briggs JA; Morris SW; Olson MO; Kinney MC; Briggs RC
    Exp Hematol; 1997 Oct; 25(11):1111-7. PubMed ID: 9328447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleophosmin is required for DNA integrity and p19Arf protein stability.
    Colombo E; Bonetti P; Lazzerini Denchi E; Martinelli P; Zamponi R; Marine JC; Helin K; Falini B; Pelicci PG
    Mol Cell Biol; 2005 Oct; 25(20):8874-86. PubMed ID: 16199867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells.
    Li J; Zhang X; Sejas DP; Pang Q
    Leuk Res; 2005 Dec; 29(12):1415-23. PubMed ID: 15964625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleophosmin: a versatile molecule associated with hematological malignancies.
    Naoe T; Suzuki T; Kiyoi H; Urano T
    Cancer Sci; 2006 Oct; 97(10):963-9. PubMed ID: 16984370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA aptamers interfering with nucleophosmin oligomerization induce apoptosis of cancer cells.
    Jian Y; Gao Z; Sun J; Shen Q; Feng F; Jing Y; Yang C
    Oncogene; 2009 Nov; 28(47):4201-11. PubMed ID: 19734942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding to nucleophosmin determines the localization of human and chicken ARF but not its impact on p53.
    Moulin S; Llanos S; Kim SH; Peters G
    Oncogene; 2008 Apr; 27(17):2382-9. PubMed ID: 17968318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitination of, and sumoylation by, the Arf tumor suppressor.
    den Besten W; Kuo ML; Tago K; Williams RT; Sherr CJ
    Isr Med Assoc J; 2006 Apr; 8(4):249-51. PubMed ID: 16671360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thr199 phosphorylation targets nucleophosmin to nuclear speckles and represses pre-mRNA processing.
    Tarapore P; Shinmura K; Suzuki H; Tokuyama Y; Kim SH; Mayeda A; Fukasawa K
    FEBS Lett; 2006 Jan; 580(2):399-409. PubMed ID: 16376875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein.
    den Besten W; Kuo ML; Williams RT; Sherr CJ
    Cell Cycle; 2005 Nov; 4(11):1593-8. PubMed ID: 16205118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic role of nucleophosmin/B23.
    Yung BY
    Chang Gung Med J; 2007; 30(4):285-93. PubMed ID: 17939258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSC348884, a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis in human cancer cells.
    Qi W; Shakalya K; Stejskal A; Goldman A; Beeck S; Cooke L; Mahadevan D
    Oncogene; 2008 Jul; 27(30):4210-20. PubMed ID: 18345031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias.
    Falini B; Nicoletti I; Bolli N; Martelli MP; Liso A; Gorello P; Mandelli F; Mecucci C; Martelli MF
    Haematologica; 2007 Apr; 92(4):519-32. PubMed ID: 17488663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases.
    Colombo E; Alcalay M; Pelicci PG
    Oncogene; 2011 Jun; 30(23):2595-609. PubMed ID: 21278791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant.
    Colombo E; Martinelli P; Zamponi R; Shing DC; Bonetti P; Luzi L; Volorio S; Bernard L; Pruneri G; Alcalay M; Pelicci PG
    Cancer Res; 2006 Mar; 66(6):3044-50. PubMed ID: 16540653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shuttling imbalance of MLF1 results in p53 instability and increases susceptibility to oncogenic transformation.
    Yoneda-Kato N; Kato JY
    Mol Cell Biol; 2008 Jan; 28(1):422-34. PubMed ID: 17967869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of the interface between nucleophosmin (NPM) and p53: potential role in p53 stabilisation.
    Lambert B; Buckle M
    FEBS Lett; 2006 Jan; 580(1):345-50. PubMed ID: 16376884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleophosmin is required for chromosome congression, proper mitotic spindle formation, and kinetochore-microtubule attachment in HeLa cells.
    Amin MA; Matsunaga S; Uchiyama S; Fukui K
    FEBS Lett; 2008 Nov; 582(27):3839-44. PubMed ID: 18951898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 interacts with hRAD51 and hRAD54, and directly modulates homologous recombination.
    Linke SP; Sengupta S; Khabie N; Jeffries BA; Buchhop S; Miska S; Henning W; Pedeux R; Wang XW; Hofseth LJ; Yang Q; Garfield SH; Stürzbecher HW; Harris CC
    Cancer Res; 2003 May; 63(10):2596-605. PubMed ID: 12750285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.